Report Suspected Loperamide Misuse to FDA's MedWatch Program

Please see the January 2018 FDA notice concerning new packaging for loperamide designed to limit abuse.

Abuse of OTC loperamide (Imodium A-D, etc) is skyrocketing...and is being linked to serious arrhythmias and deaths.

Loperamide used to be Schedule V. But it went OTC in the 1980s...since its abuse potential was thought to be very low.

Fast-forward to 2016 and loperamide has earned the nickname "poor man's methadone"...because high doses can lead to opioid-like effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote